Co-Diagnostics Inc. Announces Q2 2026 Quarterly Financial Results

What Happened
Co-Diagnostics, Inc. announced its financial results for the quarter ended June 30, 2026 by filing an 8-K on August 13, 2026 and furnishing a press release. The company’s press release, which is provided as an exhibit to the 8-K, includes discussion of the company’s quarterly results and references use of a non‑GAAP financial measure.

Key Details

• Filing date: August 13, 2026 (Form 8-K).
• Reporting period: quarter ended June 30, 2026 (quarterly results / earnings disclosure).
• Press release furnished as Exhibit 99.1 to the Form 8-K.
• Press release includes information about the company’s use of a non‑GAAP financial measure; reconciliation or further detail should be in the press release.

Why It Matters
This 8-K signals Co-Diagnostics’ public release of its recent quarterly results and any related earnings or revenue metrics—information that can affect investor decisions and share price. Because the filing references non‑GAAP measures, investors should review the furnished press release (Exhibit 99.1) for the specific figures, reconciliations, and management commentary to understand the company’s reported performance.